Skip to main content

Seaport Therapeutics, Inc.

corporate_fare Company Profile

Seaport Therapeutics, Inc.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed SPTX - Latest Insights

SPTX
May 06, 2026, 4:26 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
ARCH Venture Partners Discloses 11.9% Stake in Seaport Therapeutics Post-IPO, Including $19.8M IPO Purchase
Sentiment: Positive
View Wiseek Article
SPTX
May 04, 2026, 6:02 PM EDT
Filing Type: 4
Importance Score:
9
ARCH Venture Partners Makes $19.8M Open Market Purchase in Seaport Therapeutics Post-IPO, Signaling Strong Confidence
Sentiment: Positive
View Wiseek Article
SPTX
May 01, 2026, 5:31 PM EDT
Filing Type: 424B4
Importance Score:
9
Seaport Therapeutics Prices Initial Public Offering at $18.00 Per Share, Raising $254.88 Million for Clinical Development
Sentiment: Positive
View Wiseek Article
SPTX
Apr 30, 2026, 9:58 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Seaport Therapeutics Prices Upsized IPO, Signaling Strong Market Demand
Sentiment: Positive
View Wiseek Article